Skip to main content
Erschienen in: Journal of General Internal Medicine 8/2016

28.03.2016 | Perspective

Is 60 the New 80 in Hypertension?

verfasst von: Matthew C. Pflederer, MD, Raymond O. Estacio, MD, Mori J. Krantz, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

ABSTRACT

Since the release of the “2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)”, much controversy has ensued over the appropriate systolic blood pressure goal for those over the age of 60 years. This guideline suggested liberalizing the target for this population to <150 mmHg, moving away from previous guidelines suggesting a target of <140 mmHg. While some national quality measures have accepted the new relaxed blood pressure goal, the American Heart Association and American College of Cardiology have not. Recently published data show that millions of adults over 60 years of age would be classified as controlled using a threshold of <150 mmHg, but not with a target of <140 mmHg. In addition, emerging randomized trial evidence suggests that targeting a systolic blood pressure well below 140 mmHg is beneficial in older adults. In light of the improved health and vitality of older adults, and the steady decline in cardiovascular and cerebrovascular mortality over recent decades, we do not think it is in good judgment to liberalize the treatment target in adults less than 80 years of age.
Literatur
4.
Zurück zum Zitat James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013;311:507–20.CrossRef James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013;311:507–20.CrossRef
5.
Zurück zum Zitat Wright JT, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014;160:499–503.CrossRefPubMed Wright JT, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014;160:499–503.CrossRefPubMed
6.
Zurück zum Zitat Navar-Boggan AM, Pencina MJ, Williams K, et al. Proportion of US adults potentially affected by the 2014 hypertension guidelines. JAMA. 2014;311:1424–9.CrossRefPubMed Navar-Boggan AM, Pencina MJ, Williams K, et al. Proportion of US adults potentially affected by the 2014 hypertension guidelines. JAMA. 2014;311:1424–9.CrossRefPubMed
7.
Zurück zum Zitat Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systemic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.CrossRefPubMedPubMedCentral Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systemic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Mozaffarian D, Benjamin EJ, Go AS, On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:29–322.CrossRef Mozaffarian D, Benjamin EJ, Go AS, On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:29–322.CrossRef
9.
Zurück zum Zitat Lackland DT, Roccella EJ, Deutsch AF, On behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, Council on Functional Genomics and Translational Biology, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45:315–353.CrossRefPubMed Lackland DT, Roccella EJ, Deutsch AF, On behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, Council on Functional Genomics and Translational Biology, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45:315–353.CrossRefPubMed
10.
Zurück zum Zitat Borden WB, Maddox TM, Tang F, et al. Impact of the 2014 expert panel recommendation for management of high blood pressure on contemporary cardiovascular practice. J Am Coll Cardiol. 2014;64:2196–203.CrossRefPubMed Borden WB, Maddox TM, Tang F, et al. Impact of the 2014 expert panel recommendation for management of high blood pressure on contemporary cardiovascular practice. J Am Coll Cardiol. 2014;64:2196–203.CrossRefPubMed
11.
Zurück zum Zitat Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertensive patients 80 years of age or older. NEJM. 2008;358:1887–98.CrossRefPubMed Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertensive patients 80 years of age or older. NEJM. 2008;358:1887–98.CrossRefPubMed
12.
Zurück zum Zitat SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–64.CrossRef SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–64.CrossRef
13.
Zurück zum Zitat Miedemia MD, Lopez FL, Blaha MJ, et al. Implications of the Eighth Joint National Committee guidelines for the management of high blood pressure for aging adults: Atherosclerosis Risk in Communities Study. Hypertension. 2015;66:474–80.CrossRef Miedemia MD, Lopez FL, Blaha MJ, et al. Implications of the Eighth Joint National Committee guidelines for the management of high blood pressure for aging adults: Atherosclerosis Risk in Communities Study. Hypertension. 2015;66:474–80.CrossRef
14.
Zurück zum Zitat Fontil V, Pletcher M, Khanna R, et al. Physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006–2010. J Gen Intern Med. 2014;3:468–76.CrossRef Fontil V, Pletcher M, Khanna R, et al. Physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006–2010. J Gen Intern Med. 2014;3:468–76.CrossRef
16.
Zurück zum Zitat Sipahi I, Swaminathan A, Natesan V, et al. Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials. Stroke. 2012;43:432–40.CrossRefPubMed Sipahi I, Swaminathan A, Natesan V, et al. Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials. Stroke. 2012;43:432–40.CrossRefPubMed
17.
Zurück zum Zitat Czernichow S, Zanchetti A, Turnbull F, et al. Blood Pressure Lowering Treatment Trialists’ Collaboration. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens. 2011;29:4–16.CrossRefPubMed Czernichow S, Zanchetti A, Turnbull F, et al. Blood Pressure Lowering Treatment Trialists’ Collaboration. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens. 2011;29:4–16.CrossRefPubMed
18.
Zurück zum Zitat The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2013–2116.CrossRef The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2013–2116.CrossRef
19.
Zurück zum Zitat Cushman WC, Evans GW, Byington RP, et al. Effects of intensive vs. standard blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.CrossRefPubMed Cushman WC, Evans GW, Byington RP, et al. Effects of intensive vs. standard blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.CrossRefPubMed
20.
Zurück zum Zitat Rosendorff C, Lackland DT, Allison M, et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol. 2015;65:1998–2038.CrossRefPubMed Rosendorff C, Lackland DT, Allison M, et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol. 2015;65:1998–2038.CrossRefPubMed
21.
Zurück zum Zitat Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens. 2014;32:3–15.CrossRef Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens. 2014;32:3–15.CrossRef
22.
Zurück zum Zitat Bress AP, Tanner RM, Hess R, Colantonio LD, Shimbo D, Muntner P. Generalizability of results from the Systolic Blood Pressure Intervention Trial (SPRINT) to the US adult population. J Am Coll Cardiol. 2015. doi:10.1016/j.jacc.2015.10.037. Bress AP, Tanner RM, Hess R, Colantonio LD, Shimbo D, Muntner P. Generalizability of results from the Systolic Blood Pressure Intervention Trial (SPRINT) to the US adult population. J Am Coll Cardiol. 2015. doi:10.​1016/​j.​jacc.​2015.​10.​037.
Metadaten
Titel
Is 60 the New 80 in Hypertension?
verfasst von
Matthew C. Pflederer, MD
Raymond O. Estacio, MD
Mori J. Krantz, MD
Publikationsdatum
28.03.2016
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 8/2016
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3649-7

Weitere Artikel der Ausgabe 8/2016

Journal of General Internal Medicine 8/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.